Want to join the conversation?
Pharma company $SCLN and biopharma company Soligenix said they have signed a license deal granting rights to $SCLN to develop, promote, market, distribute and sell SGX942, being developed for treating oral mucositis in patients with head and neck cancer. The deal includes China, Hong Kong and Macau, as well as Taiwan, South Korea and Vietnam.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.